Your Call Is Important To Us By James Howard Kunstler

New Post Public Reply Private Reply Replies (0) Message Board
SaltyMutt
Your Call Is Important To Us

By James Howard Kunstler
May 19, 2014

Funny how, in the current national rapture of techno-narcissism, it is harder than ever to do something that for generations used to be as simple as pie: to get somebody on the telephone. It’s especially funny in a time when phones have become a prosthetic extension of every human hand and pretty much the be-all and end-all of human culture. I hold a phone, therefore I am!

It’s not so funny that the places where it is most difficult to connect to a live human being are among the most critical activities, most particularly every branch of health care. Hospitals now operate under the entirely false and obviously dishonest premise that a robotic phone routing system is the best way to handle communications. Notice that, in the logic of this system, no distinction is made between mundane business and medical emergencies. Everybody who calls get’s the same perky robot —always a woman, by the way, in a dishonest attempt to provide false reassurance that a “caring” presence (Big Sister) is at the other end of the line. Whether you call about a billing error or having just shredded your foot in a rototiller, the message at the other end will always be democratically the same: “Your call is important to us.” (Not.)

I dwell on these matters because I spent an inordinate amount of time last week calling around to several hospitals and doctors offices to get some of my medical records for a lawsuit I am prosecuting against the manufacturer of a defective hip implant that gave me cobalt / chromium poisoning. Note also that we have contrived to make it nearly impossible to obtain our own medical records.

Now I am, going to reveal to you why it is so difficult to get a live human being on the telephone at these important places: because the more of a racketeering matrix medicine becomes, the more it seeks to evade responsibility for the consequences. That is, the more medicine becomes a criminal enterprise, the less it wants to hear from its client/victims. The same ethos is at work in just about every other realm of corporate enterprise in the USA. Our problem in the USA is not “capitalism,” it’s racketeering. Why we fail to comprehend it is one of the abiding mysteries of contemporary life.

The biggest offender after medicine, of course, is banking. They don’t want to hear from you either. They enjoy the privilege of swindling you by both tiny-and-large increments on transaction payments and near-zero interest rates and mortgage contracts where no title record of collateral can be located, and that all works very nicely for them. But they’re too busy creaming off profits to talk to their customers. In both medicine and banking, even the few remaining human secretaries to whose answering machines calls are torturously routed will not return those phone calls. “Your call is important to us.” (Not.)

Now all of this raises a couple of questions. How did we get to this sorry place? And why are citizens not violently angry about it?

To some degree, this situation represents the sheer diminishing returns and unintended consequences of technology. In a nation infatuated with technology, these entropic effects are always ignored. We just don’t want to hear about it, and our related infatuation with feel-good public relations bullshit spews a fog of concealment over it. We apparently like being deceived and don’t mind being tortured.

Robot phone answering systems also allowed corporations to off-load the cost of doing business onto their customers, mostly in the form of wasting vast amounts of their customers’ time. Included in the off-load was the cost of paying receptionists (as telephone answerers used to be quaintly called) and all their medical and retirement benefits — just another manifestation of the vanishing middle class, by the way, since a lot of women used to be employed that way (let’s skip the gender equality side-bar for now). After a while, the added privilege of companies being able to evade responsibility for their actions hugely outweighed the cost-saving advantage of firing some lower level employees.

It ought to be self-evident that this could only happen in a profoundly corrupt, dishonest, and degenerate society, because it took the form of a social compact that accepted this sort of behavior as okay. Doctors especially don’t want to be accessible to their customers. It enhances their aura of supernatural authority to be as unreachable as possible — and most of them these days are safely embedded in the protective corporate matrix one way or another as well. I suppose you can always pray to them and hope for a reply, since that is obviously the system they are trying to emulate. And, after all, this is an especially pious society. But try asking a plain question like, “how come you charged me $34,000 for four hours of anesthesia?” and you will be hung out to dry until the end of time.

As for outrage, I am frankly amazed that the various armed lunatics at large in America are so busy shooting up schools when many more people are actually being harmed, indeed ruined, by the health care “industry” and the banks.

If you have a theory about all this, please offer it up in the Comments department.

http://kunstler.com/clusterfuck-nation/your-c...ant-to-us/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 469

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 181

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 848

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 150

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 117

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 423

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 734

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 176

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading

Top 5 Most Recently Viewed Articles

MacGregor's Bold Play: RoRo Tech for TT-Line's Ferries

Updated Category News Views 51

A Green Wave in the Baltic It looks like MacGregor's betting big on the future of maritime transport, and they're putting their chips down on TT-Line's next-gen battery-hybrid LNG ferries. With a contract fresh out of the oven, they've signed up to kit out these eco-warriors with a range of RoRo equipment. And let me tell you, this is no piddly order—by any stretch,...

Continue Reading
WAVE Life Sciences: Rising Share Value Amid DMD Innovations

Updated Category News Views 50

Recent Developments at WAVE Life Sciences B.Riley has maintained a Buy rating on WAVE Life Sciences (NASDAQ: WVE) and raised the price target to $19 from $11. This adjustment comes after the promising announcement regarding the company's Duchenne muscular dystrophy (DMD) drug candidate, WVE-N531. Promising DMD Drug Candidate The company's analyst highlighted an increase...

Continue Reading
First American Uranium Successfully Secures $2.86 Million Funding

Updated Category News Views 143

First American Uranium Secures Oversubscribed Financing First American Uranium Inc. is thrilled to announce the closing of its oversubscribed flow-through share financing, having raised an impressive $2.86 million from issuing a total of 2,073,262 flow-through shares. Each share was priced at $1.38, exceeding initial expectations. Funding Utilization for Exploration The...

Continue Reading
Community Healthcare Trust Reports Q2 Financial Results

Updated Category News Views 161

Summary of Financial Results Community Healthcare Trust Incorporated (NYSE: CHCT) recently announced its financial performance for the quarter ending June 30, 2025. The company reported a net loss of approximately $12.6 million or $0.50 per diluted common share. The funds from operations ("FFO") and adjusted funds from operations ("AFFO") during this period amounted to...

Continue Reading
Neuberger Fund Ups Distribution Amid Market Challenges

Updated Category News Views 169

Neuberger Boosts Distribution: What's Driving This? I ain't about to sugarcoat it: the Neuberger Next Generation Connectivity Fund (NYSE: NBXG) decided to jack up its monthly distribution rate to $0.132 per share. This announcement, hitting wallets on November 30, 2026, has a record and ex-date of November 16. Now, that's a good ol' reliable payout for folks holding NBXG...

Continue Reading